Literature DB >> 8702696

The K65R mutation confers increased DNA polymerase processivity to HIV-1 reverse transcriptase.

D Arion1, G Borkow, Z Gu, M A Wainberg, M A Parniak.   

Abstract

The K65R mutation in HIV-1 reverse transcriptase (RT) is associated with viral cross-resistance to 2',3'-dideoxyinosine, 2',3'-dideoxycytidine, and 2',3'-dideoxy-3'-thiacytidine. We have found that in vitro DNA synthesis by K65R RT is significantly more processive than that of wild type (wt) RT. Depending on the template/primer (T/P) used, the total incorporation of nucleotides under single processive cycle conditions was 20-50% higher with K65R RT than with wt RT. With heteropolymeric T/P, the total incorporation of dNMP by K65R and wt RT was similar under continuous DNA synthesis reaction conditions. However, under single processive cycle conditions, the rate of full-length polymerization product synthesis by K65R RT was about 2-fold higher than that by wt RT. We also found a decreased rate of T/P dissociation during K65R RT DNA synthesis, which is consistent with the increased processivity of the enzyme. We postulate that the increased processivity of the K65R RT may be a compensatory response to the decreased affinity of this mutant for certain dNTP substrates, allowing normal viral replication kinetics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702696     DOI: 10.1074/jbc.271.33.19860

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Site-directed mutagenesis in the fingers subdomain of HIV-1 reverse transcriptase reveals a specific role for the beta3-beta4 hairpin loop in dNTP selection.

Authors:  Scott J Garforth; Tae Woo Kim; Michael A Parniak; Eric T Kool; Vinayaka R Prasad
Journal:  J Mol Biol       Date:  2006-09-27       Impact factor: 5.469

2.  In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase.

Authors:  Urvi M Parikh; Dianna L Koontz; Chung K Chu; Raymond F Schinazi; John W Mellors
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Ab initio molecular dynamics studies on HIV-1 reverse transcriptase triphosphate binding site: implications for nucleoside-analog drug resistance.

Authors:  F Alber; P Carloni
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

4.  Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity.

Authors:  Kirsten L White; Nicolas A Margot; Terri Wrin; Christos J Petropoulos; Michael D Miller; Lisa K Naeger
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

5.  Mutational analysis of Lys65 of HIV-1 reverse transcriptase.

Authors:  N Sluis-Cremer; D Arion; N Kaushik; H Lim; M A Parniak
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

6.  Structural basis for activation of alpha-boranophosphate nucleotide analogues targeting drug-resistant reverse transcriptase.

Authors:  P Meyer; B Schneider; S Sarfati; D Deville-Bonne; C Guerreiro; J Boretto; J Janin; M Véron; B Canard
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

Review 7.  Genotypic testing for human immunodeficiency virus type 1 drug resistance.

Authors:  Robert W Shafer
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

8.  Human immunodeficiency virus type 1: resistance to nucleoside analogues and replicative capacity in primary human macrophages.

Authors:  Danielle Perez-Bercoff; Sébastien Wurtzer; Séverine Compain; Henri Benech; François Clavel
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

9.  Substitution of alanine for tyrosine-64 in the fingers subdomain of M-MuLV reverse transcriptase impairs strand displacement synthesis and blocks viral replication in vivo.

Authors:  Benjamin A Paulson; Miaohua Zhang; Sharon J Schultz; James J Champoux
Journal:  Virology       Date:  2007-05-29       Impact factor: 3.616

10.  In vitro suppression of K65R reverse transcriptase-mediated tenofovir- and adefovir-5'-diphosphate resistance conferred by the boranophosphonate derivatives.

Authors:  Antoine Frangeul; Karine Barral; Karine Alvarez; Bruno Canard
Journal:  Antimicrob Agents Chemother       Date:  2007-07-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.